Medicare Wastes Billions on Name-Brand Drugs

Medicare wastes billions on name-brand drugs

Filed under: drug abuse treatment outcome study

Numerous studies show that generics, which must meet rigid Food and Drug Administration standards, work as well as name brands for most patients. Although some medications do not have exact generic versions, there usually is a similar one in the same …
Read more on Delaware County Daily Times

Ariad Able to Continue Its EU Iclusig Sales; Threshold Reports New Clinical …

Filed under: drug abuse treatment outcome study

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD ) , announced early data from the Phase 1 portion of an investigator-sponsored Phase 1/2 trial of its investigational hypoxia-targeted drug TH-302 in combination with Avastin(R) (bevacizumab) in patients …
Read more on HispanicBusiness.com

How Clinical Guidelines Can Fail Both Doctors and Patients

Filed under: drug abuse treatment outcome study

In the late 1960s legislation for the U.S. Food and Drug Administration was amended to call for a demonstration of efficacy and an assessment of benefits and risk as prerequisite to the licensing of any pharmaceutical. Modern clinical science resulted …
Read more on Scientific American (blog)

Patient Compliance – Cracking that Big Nut!

Filed under: drug abuse treatment outcome study

Unfortunately, the patient, perhaps unconvinced of the drug's benefits, either doesn't fill the prescription or fails to properly adhere to the treatment regime – that's assuming they even present in the first place. The consequence for many patients …
Read more on PMLiVE